50 likes | 65 Views
The global single-cell analysis market is projected to reach USD 6.3 billion by 2026 from USD 3.1 billion in 2021, at a CAGR of 15.1% during the forecast period.
E N D
Single Cell Analysis Market Global Forecast to 2026 Single Cell Analysis Market is expected to reach $ 6.3 Billion by 2026 Growing at a CAGR of 15.1% (2021 – 2026)
The global single-cell analysis market is projected to reach USD 6.3 billion by 2026 from USD 3.1 billion in 2021, at a CAGR of 15.1% during the forecast period.
The consumables segment accounted for the largest share of the product segment in the single-cell analysis market in 2020. Consumables accounted for the largest share of the single-cell analysis market in 2020. The large share of this segment can primarily be attributed to the frequent purchase of these products compared to instruments, which are considered a one-time investment. The wide applications of consumables in research and genetic exploration, exosome analysis, and isolation of RNA and DNA are also expected to drive market growth.
The research applications segment accounted for the largest share of the application segment in the single-cell analysis market in 2020 Based on applications, the single-cell analysis market is segmented into research and medical applications. The research applications segment accounted for the largest share of the single-cell analysis market in 2020. Increasing government initiatives in stem cell research and the wide usage of single-cell analysis in cancer research are the major factors driving the growth of the research applications segment.
Key Market Player Danaher Corporation (US), Merck KGAA (Germany), QIAGEN N.V. (Netherlands), Thermo Fisher Scientific, Inc. (US), Promega Corporation (US), Illumina, Inc. (US), Fluidigm Corporation (US), 10X Genomics (US), and Corning Incorporated (US).